Completed NA INTERVENTIONAL 1-arm NCT01745484

Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation

Role of SPECT in Radiotherapy Treatment Planning and Toxicity Evaluation for the Patients With Stage I-III NSCLC

Sponsor: University of Aarhus

Conditions Non-small-cell Lung Cancer Radiation Pneumonitis

Interventions SPECT-based treatment plan

Updated 6 times since 2017 Last updated: Apr 23, 2019 Started: Jun 30, 2012 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Non-small-cell Lung Cancer and Radiation Pneumonitis and is currently completed. University of Aarhus leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark